Post Resch Tallon Group Inc.

Position in CRDF — Cardiff Oncology, Inc.

CIK 2054476 PITTSFORD, NY

Position in CRDF

as of Jun 30, 2026 · filed Jul 7, 2026 Compact

Position Value

$29,269

-$7,205 QoQ

Shares Held

22,515

0.0% QoQ

Ownership

0.033%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

of 22 holders

Holding Since

Sep 2025

4 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Post Resch Tallon Group Inc. holds $4,357,094 across 5 Biotechnology names. CRDF ranks #5 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	50,397	$2,742,100
2	CDXS	Codexis, Inc.	563,478	$1,273,460
3	SNDX	Syndax Pharmaceuticals Inc	12,500	$273,250
4	AGEN	Agenus Inc	12,750	$39,015
5	CRDF	Cardiff Oncology, Inc. This page	22,515	$29,269

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$29,269	22,515	0.0%	Shares	Sole	2026-07-07
2026-03-31	$36,474	22,515	+0.1%	Shares	Sole	2026-04-08
2025-12-31	$63,233	22,503	-0.2%	Shares	Sole	2026-01-09
2025-09-30	$46,428	22,538	—	Shares	Sole	2025-11-05
No filing history on record for this holder in this stock.